SecBot SecBot
Insider Cluster (2 insiders) ·Filed May 19, 2026

BBIO

BridgeBio Pharma, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed6mo ago
Insider cluster: 2 insiders, $1.1M total
Actionable Insight • Neutral

The insider selling is trivial in size and likely reflects post-earnings window opening and tax planning. The concurrent $500M ATM offering introduces potential dilution overhang, but the $500M buyback authorization partially offsets this. Monitor the pace of ATM usage and any insider purchases as a signal of management conviction.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$68.22
T+0 close · May 19, 2026 · via day close
Latest settled
+17.06%
T+60 · $79.86
Vs SPY
+12.06%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 20 $68.22entry
  2. T+1 · 6mo ago +3.02%α +2.83% · $70.28
  3. T+5 · 6mo ago +0.34%α −1.47% · $68.45
  4. T+20 · 5mo ago −2.86%α −3.60% · $66.27
  5. T+60 · 3mo ago +17.06%α +12.06% · $79.86

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

A cluster of insider selling at BridgeBio Pharma (BBIO) occurred in the week following the Q1 2026 earnings release and the filing of a $500M at-the-market (ATM) equity offering. CFO Thomas Trimarchi sold $678K in open-market shares, and Director Randal Scott sold $413K, while CEO Neil Kumar exercised options and surrendered shares for tax withholding. The total open-market sales of $1.09M represent ~0.009% of BBIO's $12.8B market cap, which is trivial. The cluster is likely driven by routine post-earnings blackout window opening and tax-related transactions, not a coordinated bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$1.1M
Insiders
2

Key Facts

  • CFO Thomas Trimarchi sold 10,456 shares for $678K on May 18, 2026.
  • Director Randal Scott sold 6,200 shares for $413K on May 15, 2026.
  • CEO Neil Kumar exercised 33,544 options (non-cash) and surrendered 36,236 shares for tax withholding ($2.4M).
  • Total open-market selling of $1.09M is only 0.009% of BBIO's $12.8B market cap.
  • Q1 2026 revenue was $194.5M, including $180.6M in Attruby net product revenue.
  • Company filed a $500M ATM equity offering on May 7, 2026, concurrent with a $500M share buyback authorization.
  • Cash and marketable securities stood at $940.2M as of March 31, 2026.

Financial Impact

Open-market insider sales total $1.09M, which is immaterial relative to BBIO's $12.8B market cap.

dilutioncash

Risk Factors

  • The $500M ATM equity offering could dilute existing shareholders if fully utilized.
  • Insider selling, while small, may continue if the stock appreciates further.
  • Pipeline execution risk for BBP-418, encaleret, and infigratinib NDAs.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
97% bullish (30 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-BBIO-1779222659731

Track record

38 reports on BBIO

Performance horizon

10 of 13 bullish or bearish reports moved the stock their way by T+20. Best: +26.76% at T+60 after the May 11, 2026 report. 14 of 15 went positive at some point.

Filters
  1. Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $78.17 Now $77.36 −1.04% settles Dec 11
  2. Nov 9, 20267d ago Institutional Cluster Bullish 4/10 Entry $77.93 Now $77.36 −0.73% settles Dec 8
  3. Nov 6, 202610d ago Press Release Neutral 2/10 Entry $77.93 Now $77.36 −0.73% settles Dec 8
  4. Oct 29, 202618d ago 8-K Bullish 6/10 No price data
  5. Oct 29, 202618d ago Press Release Bullish 6/10 Entry $74.95 Now $77.36 +3.22% settles Nov 30
  6. Oct 27, 202620d ago SC 13G Neutral 3/10 Entry $70.82 Now $77.36 +9.23% settles Nov 25
  7. Oct 22, 202625d ago Press Release Neutral 1/10 Entry $68.12 Now $77.36 +13.56% settles Nov 19
  8. Oct 13, 20264w ago 8-K Bullish 7/10 Entry $63.30 to $78.67 Now $77.36 +22.21% ▲ +24.28% +27.89% vs SPY
  9. Oct 6, 20265w ago Press Release Bullish 7/10 Entry $66.96 to $74.03 Now $77.36 +15.53% ▲ +10.56% +13.73% vs SPY
  10. Oct 5, 20266w ago Press Release Neutral 2/10 Entry $66.96 to $74.03 Now $77.36 +15.53% ▲ +10.56% +13.73% vs SPY
Showing 10 of 38

US Market Status

Market Closed · Opens Wed (13h 50m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 19, 2026